M34 actin regulatory protein is a sensitive diagnostic marker for early- and late-stage mammary carcinomas

Clinical Cancer Research

Volumn 10, Issue 13, 2004, Pages 4437-4443

  Soriano, Zoraida ^a   Pardee, Joel D ^a  

^a Weill Cornell Graduate School of Biomedical Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN REGULATORY PROTEIN; M34 PROTEIN; REGULATOR PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ACTIN FILAMENT; ADENOCARCINOMA; ADULT; AGED; ARTICLE; BREAST CANCER; BREAST CARCINOMA; BREAST DUCT; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; FIBROADENOMA; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; LYMPH NODE METASTASIS; MALIGNANT TRANSFORMATION; POSTMENOPAUSE; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACTINS; ADENOCARCINOMA; AGED; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; FIBROADENOMA; HUMANS; IMMUNOBLOTTING; LYMPH NODES; LYMPHATIC METASTASIS; MICROFILAMENT PROTEINS; MICROFILAMENTS; MIDDLE AGED; NEOPLASM METASTASIS; PAPILLOMA; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 3042770816     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-0544-3     Document Type: Article

References (29)

1. Jemal A, Thomas A, Murray T, Thun M. Cancer statistics, 2002. CA Cancer J Clin 2002;52:23-47.
2. American Cancer Society. Estimated cancer deaths and new cases by sex and site: 1971 cancer facts and figures. New York: American Cancer Society, 1970.
3. Dowlatshahi K, Fan M, Bloom KJ, Spitz KJ, Patel S, Snider HC. Occult metastases in the sentinel lymph nodes of patients with early stage breast carcinoma: a preliminary study. Cancer 1999;86:990-6.
4. Rosen PP, Goshen S, Saigo PE, Kinne DW, Hellman S. A long-term follow-up study of survival in state I (T1N0M0) and stage II (T1N1M0) breast carcinoma. J Clin Oncol 1989;7:355-6.
5. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancer. Lancet 1991;335:1565-8.
6. Sidransky D. Emerging molecular markers of cancer. Nat Rev Cancer 2002;2:210-9.
7. Sedmak D, Meinecke TA, Knechtges DS, Anderson J. Prognostic significance of cytokeratin-positive breast cancer metastases. Mod Pathol 1989;2:516-20.
8. Canizares F, Sola J, Perez M, et al. Properative values of CA15-3 and CEA as prognostic factors in breast cancer: a multivariate analysis. Tumour Biol 2001;22:273-81.
9. Sjostrom J, Alfthan H, Joensuu H, Stenman UH, Lundin J, Blomqvist C. Serum tumour markers CA15-3, TPA, hCGb and TATI in the monitoring of chemotherapy response in metastatic breast cancer. Scand J Clin Lab Investig 2001;61:431-41.
10. Srinivas PR, Srivastava S, Hanash S, Wright GL Jr. Proteomics in early detection of cancer. Clin Chem 2001;47:1901-11.
11. Rawlings CJ, Searls DB. Computational gene discovery and human disease. Curr Opin Genet Dev 1997;7:416-23.
12. Boecker W, Buerger H, Schmitz K, et al. Ductal epithelial proliferations of the breast: A biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns. J Pathol 195:401-3.
13. Fernandez C, Liprandi A, Bouvier-Labit C, Figarella-Branger D. Value of cytokeratin 7 and 20 for the diagnosis of cerebral metastases of adenocarcinoma: study of 78 cases. Ann Pathol 2001;21:129-35.
14. Bosma AJ, Weigelt B, Lambrechts AC, et al. Detection of circulating breast tumor cells by differential expression of marker genes. Clin Cancer Res 8:1871-7.
15. Kobayashi M, Ooi Y, Oda Y, Nakanishi I. Protein overexpression and gene amplification of c-erbB-2 in breast carcinomas: a comparative study of immunohistochemistry and fluorescence in situ hybridization of formalin-fixed, paraffin-embedded tissues. Hum Pathol 2002;33:21-8.
16. Silva AL, Diamond J, Silva MR, Passos-Coelho JL. Cytokeratin 20 is not a reliable molecular marker for occult breast cancer cell detection in hematological tissues. Breast Cancer Res Treat 2001;66:59-66.
17. Johns JA, Brock AM, Pardee JD. Colocalization of F-actin and 34-kilodalton actin bundling protein in Dictyostelium amoebae and cultured fibroblasts. Cell Motil Cytoskel 1988;9:205-18.
18. Fechheimer, M. The Dictyostelium discoideum 30,000-dalton protein is an actin filament-bundling protein that is selectively present in filipodia. J Cell Biol 1987;104:1539-51.
19. Laemmli UK, Favre M. Maturation of the head of bacteriophage T4. J Mol Biol 1973;80:575-99.
20. Towbin H, Straehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350-4.
21. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
22. Taback B, Chan AD, Kuo CT, et al. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: Correlation with clinical state of disease. Cancer Res 2001;61:8845-50.
23. Asch HL, Head K, Dong Y, et al. Widespread loss of gelsolin in breast cancers of humans, mice, and rats. Cancer Res 1996;56:4841-5.
24. Folger PA, Berg WJ, DeJesus Z, Fong Y, Pardee JD. A mammalian severin replaces gelsolin in transformed epithelial cells. Cancer Res 1999;59:5349-55.
25. Yamashiro S, Yamakita Y, Ono S, Matsumura S. Fascin, an actin-bundling protein, induces membrane protrusions and increases cell motility of epithelial cells. Mol Biol Cell 1998;9:993-1006.
26. Said JW, Pinkus JL, Shintaku IP, et al. Alterations in fascin-expressing germinal center dendritic cells in neoplastic follicles of B-cell lymphomas. Mod Pathol 1998;11:1-5.
27. Gluck U, Kwiatkowski DJ, Ben-Ze'ev A. Suppression of tumorigenicity in simian virus 40-transformed 3T3 cells transfected with alpha-actinin cDNA. Proc Natl Acad Sci USA 90:383-7.
28. Jones SL, Wang J, Turck CW, Brown EJ. A role for the actin-bundling protein L-plastin in the regulation of leukocyte integrin function. Proc Natl Acad Sci USA 1998;95:9331-6.
29. Park T, Chen ZP, Leavitt J. Activation of the leukocyte plastin gene occurs in most human cancer cells. Cancer Res 1994;54:1775-81.